Sign in
CompletedNo phase

Effectiveness of Hemi- Versus Total Shoulder Arthroplasty Using Implants of the "Epoca" System

Key facts

Who runs it
AO Innovation Translation Center
Where
Austria, Germany, and Sweden4 sites in 3 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
76 people enrolled
Started
Sept 2011
Ended
Jun 2024
Type of study
Interventional, 2 groups
Treatments tested
  • Hemiarthroplasty
  • Total arthroplasty
Record updated
1 July 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Age 18 years and older
  • Primary or secondary omarthrosis (eg, rheumatoid arthritis, avascular head necrosis)
  • Glenoid morphologic type A1, A2 or B1 according to Walch
  • Ability to understand the content of the patient information / informed consent form and to participate in the clinical investigation
  • Written informed consent

Who cannot take part

  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study; Intraoperative:
  • Intraoperative decision to use implants other than Epoca
  • Patients with a severe systemic disease: class III-IV according to the American Society of Anaesthesiologists physical status classification (ASA)
  • Preoperative:
  • Posttraumatic omarthrosis
  • Biconcave aspect of glenoid (Walch type B2)
  • Retroversion of glenoid more than 25° (Walch type C)
  • "Epoca Reko" prosthesis
  • Humerus fractures
  • Substance abuse that would preclude reliable assessment
  • Pregnancy
  • Prisoners
  • Full thickness tear of rotator cuff
  • Indication for hemiarthroplasty only
  • Indication for total arthroplasty only

Where is this trial?

It has sites in 3 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The clinical question on whether or not to replace the glenoid component in patients with a degenerative shoulder disease, has not been answered yet in a randomized study with enough statistical power. In this study, patients are randomly allocated to a treatment with a hemi- or total shoulder arthroplasty using implants of the Epoca system. The primary objective is the comparison of pain and function between the treatment groups after 5 years using the Constant score.

The 2 groups in the trial

  • HemiarthroplastyOther group

    Patients are treated with hemi shoulder arthroplasty with CE marked medical devices of the Epoca system.

  • Total arthroplastyOther group

    Patients are treated with total shoulder arthroplasty with CE marked medical devices of the Epoca system.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized Multicenter Study Comparing the Effectiveness of Hemi Versus Total Shoulder Arthroplasty in Patients With a Degenerative Joint Disease
Record updated
1 July 2024